Rosamultic acidCAS# 214285-76-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 214285-76-4 | SDF | Download SDF |
| PubChem ID | 102004711 | Appearance | Powder |
| Formula | C30H46O5 | M.Wt | 486.7 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (3S,3aR,5aR,5bS,7aS,10R,11R,11aS,13aS,13bR)-11-hydroxy-1,3-bis(hydroxymethyl)-3,5a,5b,10,11,13b-hexamethyl-4,5,6,7,8,9,10,11a,13,13a-decahydro-3aH-cyclopenta[a]chrysene-7a-carboxylic acid | ||
| SMILES | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(C(=CC5(C)CO)CO)C)C)C2C1(C)O)C)C(=O)O | ||
| Standard InChIKey | KQDIKHGGEUXUOH-JNRFZGABSA-N | ||
| Standard InChI | InChI=1S/C30H46O5/c1-18-9-12-30(24(33)34)14-13-26(3)20(23(30)29(18,6)35)7-8-22-27(26,4)11-10-21-25(2,17-32)15-19(16-31)28(21,22)5/h7,15,18,21-23,31-32,35H,8-14,16-17H2,1-6H3,(H,33,34)/t18-,21+,22+,23-,25-,26-,27-,28+,29-,30+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Rosamultic acid is a class of triterpenes with α-glucosidase inhibitory activity. |
| Targets | CDK | Caspase | PARP |
Rosamultic acid Dilution Calculator
Rosamultic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.0547 mL | 10.2733 mL | 20.5465 mL | 41.0931 mL | 51.3663 mL |
| 5 mM | 0.4109 mL | 2.0547 mL | 4.1093 mL | 8.2186 mL | 10.2733 mL |
| 10 mM | 0.2055 mL | 1.0273 mL | 2.0547 mL | 4.1093 mL | 5.1366 mL |
| 50 mM | 0.0411 mL | 0.2055 mL | 0.4109 mL | 0.8219 mL | 1.0273 mL |
| 100 mM | 0.0205 mL | 0.1027 mL | 0.2055 mL | 0.4109 mL | 0.5137 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Demethylsuberosin
Catalog No.:BCN6508
CAS No.:21422-04-8
- 5,7-dimethoxy-2,2-dimethylchromene
Catalog No.:BCN8030
CAS No.:21421-66-9
- N-Benzylphthalimide
Catalog No.:BCC9096
CAS No.:2142-01-0
- Picrotin
Catalog No.:BCC8233
CAS No.:21416-53-5
- 1-Decarboxy-3-oxo-ceanothic acid
Catalog No.:BCN4924
CAS No.:214150-74-0
- 26-Deoxycimicifugoside
Catalog No.:BCN2906
CAS No.:214146-75-5
- Glucoraphanin
Catalog No.:BCN3817
CAS No.:21414-41-5
- Magnoflorine
Catalog No.:BCN4923
CAS No.:2141-09-5
- CART (55-102) (human)
Catalog No.:BCC6007
CAS No.:214050-22-3
- Taxiphyllin
Catalog No.:BCN4922
CAS No.:21401-21-8
- Chrysin dimethylether
Catalog No.:BCN6799
CAS No.:21392-57-4
- Barbacarpan
Catalog No.:BCN4921
CAS No.:213912-46-0
- 16alpha-Hydroxybauerenol
Catalog No.:BCN7724
CAS No.:214351-30-1
- 1400W dihydrochloride
Catalog No.:BCC7057
CAS No.:214358-33-5
- (+)-Syringaresinol
Catalog No.:BCN7496
CAS No.:21453-69-0
- AMT hydrochloride
Catalog No.:BCC6823
CAS No.:21463-31-0
- 2-Deacetyltaxachitriene A
Catalog No.:BCN7415
CAS No.:214769-96-7
- H-Arg(NO2)-OH
Catalog No.:BCC2864
CAS No.:2149-70-4
- Agrimonolide
Catalog No.:BCN4925
CAS No.:21499-24-1
- Bruceine D
Catalog No.:BCN2894
CAS No.:21499-66-1
- 7,3',4'-Trihydroxyflavone
Catalog No.:BCN4674
CAS No.:2150-11-0
- Protocatechuic acid methyl ester
Catalog No.:BCN3542
CAS No.:2150-43-8
- Methyl 2,6-dihydroxybenzoate
Catalog No.:BCN3563
CAS No.:2150-45-0
- BMS 493
Catalog No.:BCC7697
CAS No.:215030-90-3
Antiproliferative activity of rosamultic acid is associated with induction of apoptosis, cell cycle arrest, inhibition of cell migration and caspase activation in human gastric cancer (SGC-7901) cells.[Pubmed:26220626]
Phytomedicine. 2015 Aug 15;22(9):796-806.
BACKGROUND: Gastric cancer is the second leading cause of cancer related deaths after lung cancer globally. Among natural products, natural triterpenes represent a structurally diverse group of organic compounds with potent antitumor activity. PURPOSE: The objective of the present research work demonstrated the antiproliferative and apoptotic activity of Rosamultic acid, a natural triterpenoid, in human gastric cancer (SGC-7901) cells. Its effect on cellular morphology, cell cycle arrest, DNA fragmentation and expression levels of caspase-3, caspase-8 and caspase-9 were also determined. METHODS: Antiproliferative activity of Rosamultic acid was evaluated by MTT assay. Phase contrast, fluorescence microscopy as well as flow cytometry using Hoechst 33342, acridine orange/ethidium bromide and Annexin V-FITC as cellular probes were used to evaluate the induction of apoptosis by Rosamultic acid. Protein level expressions were analyzed by western blot analysis. RESULTS: The results revealed that Rosamultic acid induced dose-dependent as well as time dependent cytotoxic effects in SGC-7901 gastric cancer cells. It also led to a reduction in clonogenic activity along with inhibiting the cell migration. Characteristic features of apoptosis induced by Rosamultic acid were observed and quantified. Cell cycle arrest at sub-G1 phase was induced by Rosamultic acid along with downregulation of expression levels of CDK4, CDK6 and cyclin D1. Rosamultic acid also significantly led to the activation of caspase-3, -8 and -9 during the 48 h treatment along with cleaving PARP in a dose-dependent manner. DNA fragmentation following Rosamultic acid treatment was also observed in these cells. CONCLUSION: The current study strongly reveals that Rosamultic acid inhibits gastric cancer proliferation by inducing apoptosis mediated through cell cycle arrest, downregulation of cell cycle related protein expressions, inhibition of cell migration, DNA damage, and activation of caspases.
